Evozyne
Abigail Sulpizio, PhD, is an experienced research scientist currently working at Evozyne, where responsibilities include developing and optimizing high-throughput mammalian assays for testing Cas9 nuclease activity and managing project workflows. Prior experience includes a role as a Cell and Molecular Biologist and Biochemist at Cornell University, where Abigail independently pursued a literature-driven thesis and developed expertise in various molecular biology techniques, including Crispr-Cas9 gene manipulation. Teaching experience encompasses serving as a Cell Biology Teaching Assistant, overseeing discussion sessions and tutoring students. Previous positions also include roles at Michigan State University and Pfizer, focusing on plant biochemistry, genomic science, and quality assurance in drug production. Abigail holds a PhD in Biochemistry, Cell, and Molecular Biology from Cornell University and a Bachelor of Science in Biochemistry and Molecular Biology from Michigan State University.
Evozyne
1 followers
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.